Technologies

Avecia’s proprietary technologies are available to all customers and can bring many benefits, including:

• improved process productivity
• improved product quality
• lower cost of goods

Avecia will work with customers to evaluate all available process solutions, both proprietary and non-proprietary. Avecia’s technologies will only be applied where a clear benefit can be demonstrated.

pAVEway™

Avecia has added pAVEway™ to its growing portfolio of advanced technology solutions for the manufacture of therapeutic proteins. This new technology enables class-leading (>10g/L) microbial production of a wide range of therapeutically useful proteins (vaccines, cytokines, growth factors, etc).

Avecia’s scientists have used their expertise and understanding of the expression kinetics of existing state-of-the-art microbial systems to design and build a range of innovative expression vectors, to select a range of suitable host cells and to optimise the fermentation processes. These systems are combined in the pAVEway platform, which offers a way for fast track process creation and development. Among the unique features of pAVEway are the fully repressible basic expression and the modulatable expression induction. This enables the high level expression of a wider range of proteins than ever before.

pAVEway will help to reduce the time to market and cost, while increasing flexibility and maintaining Avecia’s high quality standards.

Click here for .pdf file of pAVEway™ brochure

Listen to Bo Kara, Director of Science & Technology, talk about the benefits of pAVEway™.